UNITY Biotechnology Announces Positive Data in Phase 2

Long

Unity Biotechnology, Inc. (NASDAQ:UBX)

NASDAQ:UBX Unity Biotechnology, Inc.

beyondta

UBX: Unity Biotechnology, Inc.
2022-08-12 07:00:00 UNITY Biotechnology Announces Positive Data in Phase 2 BEHOLD Study of UBX1325 in Patients with Diabetic Macular Edema

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.